While GHK-Cu is generally well-tolerated in topical research, certain contraindications or precautions should be considered, especially for systemic research or in specific populations: Systemic Research: For systemic applications, GHK-Cu is generally not recommended for subjects who are pregnant, breastfeeding, have active cancer, or suffer from Wilsons disease (a condition involving copper accumulation)
Glycemic control and body mass index (BMI) as risk factors for erectile dysfunction among Saudi men with diabetes: a systematic review and meta-analysis
Patience matters here
The administered therapy was a one-time intraperitoneal application of the stable gastric pentadecapeptide BPC 157, much like the one-time engraftment of neural stem cells [16] or bone marrow stromal cells [17] into the lesion site
Low ascorbate levels are associated with increased hypoxia-inducible factor-1 activity and an aggressive tumor phenotype in endometrial cancer
This interaction stabilizes Nrf2, promoting an antioxidant response that supports tumor survival